The shift in payment space to e-commerce works in Visa Inc.’s V favor because its share of digital commerce is approximately thrice the physical point of sale.
Vir Biotechnology, Inc. VIR along with its partner GlaxoSmithKline GSK announced that they are expanding their COMET-ICE study to phase III. The study is evaluating their monoclonal antibody candidate VIR-7831 for the early treatment of COVID-19 in patients who are at a high ris
MoneyGram International Inc. MGI has announced a three-year extension to its relationship with Walmart, the world's largest retailer. The deal lasting through March 2024 will extend MoneyGram's services at Walmart, named Walmart2World.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.
Humana Inc. HUM recently inked a new deal with market-leading renal care company Fresenius Medical Care North America (FMCNA). The agreement is to strengthen their partnership for better health outcomes of qualified Humana Medicare Advantage and commercial members with chronic k
The market expects Wells Fargo (WFC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful facto
The market expects Sleep Number (SNBR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful f
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key
Investors might want to bet on New Age Beverage Corporation (NBEV), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of t
Investors might want to bet on Berkeley Group Holdings PLC Unsponsored ADR (BKGFY), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of t
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key
Amedisys (AMED) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key